mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.05 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.06 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.06 |
mRNA |
PF-4708671 |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.06 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.06 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.06 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.06 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.06 |